- Home
- Publications
- Publication Search
- Publication Details
Title
Deutetrabenazine for the treatment of Huntington’s chorea
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume -, Issue -, Pages 1-7
Publisher
Informa UK Limited
Online
2018-07-12
DOI
10.1080/14737175.2018.1500178
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetics, Metabolism and Safety of Deuterated L-DOPA (SD-1077)/Carbidopa (CD) Compared to L-DOPA/CD following single oral dose administration in Healthy Subjects
- (2018) Frank Schneider et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors
- (2018) Nicki Niemann et al. DRUGS
- Neurological diseases and risk of suicide attempt: a case–control study
- (2018) Astrid Eliasen et al. JOURNAL OF NEUROLOGY
- Tardive dyskinesia: Out of the shadows
- (2018) Robert A. Hauser et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease
- (2018) Marissa Dean et al. Drug Design Development and Therapy
- Deuterated drugs; updates and obviousness analysis
- (2017) Graham S. Timmins EXPERT OPINION ON THERAPEUTIC PATENTS
- Treatment options for chorea
- (2017) H. Bashir et al. Expert Review of Neurotherapeutics
- First deuterated drug approved
- (2017) Charles Schmidt NATURE BIOTECHNOLOGY
- Randomized controlled trial of deutetrabenazine for tardive dyskinesia
- (2017) Hubert H. Fernandez et al. NEUROLOGY
- Treatment options for chorea
- (2017) H. Bashir et al. Expert Review of Neurotherapeutics
- Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea
- (2017) Samuel Frank et al. JAMA Neurology
- Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia
- (2016) Dhanya Vijayakumar et al. DRUGS
- Dopamine depleters in the treatment of hyperkinetic movement disorders
- (2016) Joseph Jankovic EXPERT OPINION ON PHARMACOTHERAPY
- Deutetrabenazine for Treatment of Chorea in Huntington Disease
- (2016) Michael D. Geschwind et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease
- (2016) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Progression of motor subtypes in Huntington’s disease: a 6-year follow-up study
- (2016) M. Jacobs et al. JOURNAL OF NEUROLOGY
- Deuterated drugs draw heavier backing
- (2016) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Deutetrabenazine—Not a Revolution but Welcome Evolution for Treating Chorea in Huntington Disease
- (2016) Ralf Reilmann JAMA Neurology
- Treating the whole body in Huntington's disease
- (2015) Jeffrey B Carroll et al. LANCET NEUROLOGY
- Chorea associated with Huntington's disease: To treat or not to treat?
- (2014) Joseph Jankovic et al. MOVEMENT DISORDERS
- Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of the Literature
- (2012) Jack J. Chen et al. CLINICAL THERAPEUTICS
- Analysis ofCYP2D6genotype and response to tetrabenazine
- (2012) Raja Mehanna et al. MOVEMENT DISORDERS
- Huntington's disease: from molecular pathogenesis to clinical treatment
- (2010) Christopher A Ross et al. LANCET NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started